PATENT CLAIM ANALYSIS

Application Number: 16125148
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "274000"]

Abstract:
The invention provides compounds of formula (I): Said compounds being modulators of Kv3 channels and of use in the prophylaxis or treatment of related disorders.

Claim (Index 34):
The method according to  claim 25 , wherein the compound of formula (I) is: (5R)-5-ethyl-3-[6-(7-methylspiro[2H-benzofuran-3,1\u2032-cyclopropane]-4-yl)oxy-3-pyridyl]imidazolidine-2,4-dione

Metadata:
- Claim Count in Document: 53.0
- Percentile: 97.0
- Lexical Diversity: 1.16
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15730559', '14361510', '15206465', '14816476', '15208329']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.849796579931475
- 35 USC 102 Novelty (BERT): 0.652528938378175
- Combined Prediction Score: 0.830069815776145
- Mean Citation Score: 574.4508440000002
- Max Citation Score: 680.4982
- Similarity Product: 592.5628375045062

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test